乙型肝炎病毒感染相关脾边缘区淋巴瘤，经病毒治疗和脾切除后缓解：病例报告及文献复习。
Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
机构信息
Department of Clinical Hematology, Military Hospital Mohammed V, Rabat, Morocco.
Department of Clinical Hematology, Military Hospital Mohammed V, Rabat, Morocco.
出版信息
Hematol Oncol Stem Cell Ther. 2021 Jun;14(2):153-155. doi: 10.1016/j.hemonc.2019.05.007. Epub 2019 Jul 9.
PMID:31306619
Abstract
We report the case of a patient diagnosed with a splenic marginal zone lymphoma with a simultaneous finding of hepatitis B virus infection, who responded to antiviral treatment and splenectomy. We highlighted this association described in the literature and its possible causal role, as well as the available therapeutic choices.
摘要
我们报告了一例诊断为伴有乙型肝炎病毒感染的脾脏边缘区淋巴瘤的患者病例，该患者对抗病毒治疗和脾切除术有反应。我们强调了文献中描述的这种关联及其可能的因果作用，以及可用的治疗选择。
相似文献
1
Splenic marginal zone lymphoma associated with hepatitis B virus infection, remission after viral treatment, and splenectomy: A case report and review of the literature.
Hematol Oncol Stem Cell Ther. 2021 Jun;14(2):153-155. doi: 10.1016/j.hemonc.2019.05.007. Epub 2019 Jul 9.
2
Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
Thromb Res. 2014 Nov;134(5):980-4. doi: 10.1016/j.thromres.2014.08.021. Epub 2014 Aug 29.
3
Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.
Int J Hematol. 2009 Dec;90(5):601-604. doi: 10.1007/s12185-009-0426-y. Epub 2009 Oct 6.
4
Remission of splenic marginal zone lymphoma in a patient treated for hepatitis B: a case of HBV-associated lymphoma.
Acta Clin Belg. 2015 Aug;70(4):301-3. doi: 10.1179/2295333715Y.0000000005. Epub 2015 May 15.
5
Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
Br J Haematol. 2021 Aug;194(3):568-579. doi: 10.1111/bjh.17577. Epub 2021 Jun 9.
6
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Leuk Res. 2016 May;44:53-60. doi: 10.1016/j.leukres.2016.03.005. Epub 2016 Mar 22.
7
[Possible contribution of disseminated Mycobacterium shigaense infection to development of splenic marginal zone lymphoma].
Rinsho Ketsueki. 2018;59(7):878-883. doi: 10.11406/rinketsu.59.878.
8
Splenic marginal zone lymphoma: current knowledge and future directions.
Oncology (Williston Park). 2012 Feb;26(2):194-202.
9
Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Br J Haematol. 2015 May;169(4):520-7. doi: 10.1111/bjh.13320. Epub 2015 Apr 8.
10
Autoimmune hemolytic anemia as a risk factor of poor outcome in patients with splenic marginal zone lymphoma.
Pathol Oncol Res. 2009 Dec;15(4):597-603. doi: 10.1007/s12253-009-9159-8. Epub 2009 Apr 3.
引用本文的文献
1
Unusual localization and clinical presentation of primary central nervous system extranodal marginal zone B‑cell lymphoma: A case report.
Oncol Lett. 2023 Aug 4;26(3):408. doi: 10.3892/ol.2023.13994. eCollection 2023 Sep.
2
Editorial: The Role of Microorganisms in Multiple Myeloma.
Front Immunol. 2022 Jun 30;13:960829. doi: 10.3389/fimmu.2022.960829. eCollection 2022.
3
Primary CNS Extranodal Marginal Zone B-Cell Lymphoma: A Case Series of 2 Patients Treated with External Beam Radiation Therapy.
Case Rep Oncol. 2021 May 21;14(2):725-732. doi: 10.1159/000515780. eCollection 2021 May-Aug.
4
Risk adapted approach: How to treat splenic marginal zone lymphoma in resource-poor settings? - The real-life experience of a Brazilian cancer treatment center.
BMC Cancer. 2020 Aug 3;20(1):717. doi: 10.1186/s12885-020-07204-6.
Zotero 插件